A randomized, open label study to determine the relative bioavailability of inhaled indacaterol given with and without oral activated charcoal for two formulations of indacaterol- lactose blend formulation and Pulmosphere based formulation in healthy adult subjects.
Phase of Trial: Phase I
Latest Information Update: 31 Aug 2016
At a glance
- Drugs Indacaterol (Primary) ; Charcoal
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacogenomic; Pharmacokinetics
- Sponsors Novartis
- 25 Feb 2013 Status changed from not yet recruiting to completed as reported by Clinical Trials Registry - India record.
- 14 May 2012 New trial record